Related Experiment Video
Updated: Sep 30, 2026

Rapid Generation of Amyloid from Native Proteins In vitro
Published on: December 5, 2013
Mutational spectrum in the MEFV and TNFRSF1A genes in patients suffering from AA amyloidosis and recurrent
Catherine Dodé1, Bouke P C Hazenberg, Christophe Pêcheux
1Laboratoire de biochimie et génétique moléculaire, Hôpital Cochin, Assistance Publique-Hôpitaux de Paris (AP-HP), Paris, France.
Background:
Among hereditary fevers characterized by recurrent attacks of fever and organ localized inflammation, familial Mediterranean fever (FMF), and tumour necrosis factor receptor superfamily 1A (TNFRSF1A) receptor associated periodic syndrome (TRAPS) are diseases with identified genes that can be associated with renal amyloidosis of the AA type. In this study we have characterized FMF and TRAPS genotypes in 38 unrelated patients suffering from amyloidosis AA and recurrent inflammatory attacks.
Methods:
Mutations of the MEFV and TNFRSF1A genes, responsible respectively for FMF and TRAPS, were searched for by amplifying, using polymerase chain reaction (PCR), genomic DNA, and direct sequencing.
Results:
Twenty-seven patients (71%) carried mutations in MEFV (22 patients with two mutations, two patients with a single mutation) or TNFRSF1A genes (three patients). Patients with MEFV mutations belonged to the classical at-risk ethnic group for FMF: Sephardic Jews, Turks, Armenians, and Arabs from the Maghreb. The main genotype encountered was M694V/M694V (19/22), one Turkish patient was M680I/M680I, and two Arab patients from the Maghreb were M694I/M694I. We found three Caucasian patients with the C55S, C70Y, R92Q mutations in the TNFRSF1A gene.
Conclusions:
In this series we observed that FMF is the main cause of AA amyloidosis in Sephardic Jews and Turks. MEFV and TNFRSF1A mutations were found in only 6 of 14 Arab patients from the Maghreb. We found three families (one Caucasian and two from Maghreb) with AA amyloidosis without MEFV or TNFRSF1A mutations, suggesting that other genetic cause(s) exist(s). The characterization of mutations in MEFV and TNFRSF1A is important for the therapeutic behaviour of AA amyloidosis associated with inherited recurrent fever.
Insights
Familial Mediterranean fever (FMF) and TRAPS are key causes of AA amyloidosis in specific ethnic groups. Genetic testing for MEFV and TNFRSF1A mutations is crucial for managing AA amyloidosis linked to inherited recurrent fevers.
Area of Science:
- Genetics
- Internal Medicine
- Rheumatology
Background:
- Familial Mediterranean fever (FMF) and tumor necrosis factor receptor superfamily 1A (TNFRSF1A) receptor-associated periodic syndrome (TRAPS) are hereditary fevers causing recurrent inflammation and AA type renal amyloidosis.
- Genetic mutations in MEFV and TNFRSF1A genes are identified causes for FMF and TRAPS, respectively.
Purpose of the Study:
- To characterize the genotypes of FMF and TRAPS in 38 unrelated patients with AA amyloidosis and recurrent inflammatory attacks.
- To investigate the genetic basis of AA amyloidosis in patients with recurrent inflammatory episodes.
Main Methods:
- Genomic DNA was extracted from 38 patients with AA amyloidosis and recurrent inflammatory attacks.
- Polymerase chain reaction (PCR) was used to amplify MEFV and TNFRSF1A genes, followed by direct sequencing to identify mutations.
Main Results:
- Mutations in MEFV or TNFRSF1A genes were identified in 27 out of 38 patients (71%).
- MEFV mutations were prevalent in Sephardic Jews, Turks, Armenians, and Arabs from the Maghreb, with M694V/M694V being the most common genotype.
- TNFRSF1A mutations were found in three Caucasian patients.
Conclusions:
- Familial Mediterranean fever (FMF) is the primary cause of AA amyloidosis in Sephardic Jews and Turks.
- MEFV and TNFRSF1A mutations were identified in a subset of Arab patients from the Maghreb, suggesting other genetic factors may be involved.
- The study identified families with AA amyloidosis lacking MEFV or TNFRSF1A mutations, indicating the existence of other genetic causes. Genetic characterization is vital for managing AA amyloidosis associated with inherited recurrent fevers.
Related Concept Videos
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Mismatch Repair
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
